Template:Cystitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) No edit summary |
Gerald Chi- (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Bacterial Uncomplicated Cystitis}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Bacterial Uncomplicated Cystitis}} | ||
|- | |- | ||
Line 29: | Line 29: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''OR''''' '''''▸ [[Beta-lactam|β-lactam]] agents for 3-7 days''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''OR''''' '''''▸ [[Beta-lactam|β-lactam]] agents for 3-7 days''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Amoxicillin-clavulanate]] 500/125 mg PO q8h or 875/125 mg PO q8h'''''<br>OR<br>▸'''''[[Cefdinir]] 300 mg PO q12h or 600 mg PO q24''''' <br>OR<br>'''''[[Cefaclor]] 250-500 mg PO q8h'''''<br>OR<br>▸'''''[[Cefpodoxime proxetil]] 100-200 mg PO q12h'''''<br>OR<br>'''''[[Cephalexin]]250-500 mg PO q6h <small> not studied well but effective</small>.''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Amoxicillin-clavulanate]] 500/125 mg PO q8h or 875/125 mg PO q8h'''''<br>OR<br>▸'''''[[Cefdinir]] 300 mg PO q12h or 600 mg PO q24''''' <br>OR<br>'''''[[Cefaclor]] 250-500 mg PO q8h'''''<br>OR<br>▸'''''[[Cefpodoxime proxetil]] 100-200 mg PO q12h'''''<br>OR<br>'''''[[Cephalexin]]250-500 mg PO q6h <small> not studied well but effective</small>.''''' | ||
|- | |- | ||
|} | |} | ||
Line 36: | Line 36: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Complicated/Catheter Associated Cystitis}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Complicated/Catheter Associated Cystitis}} | ||
|- | |- | ||
Line 57: | Line 57: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center |{{fontcolor|#FFF|Acute Cystitis in Pregnancy}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center |{{fontcolor|#FFF|Acute Cystitis in Pregnancy}} | ||
|- | |- |
Revision as of 15:40, 26 February 2014
Empiric Therapy for Acute Cystitis
|
|